
Kevin Mullin's fundraising profile shows moderate PAC reliance at 43% of total contributions, with individual donors accounting for 57% of the $2.7M raised. Industry-tied money concentrates in pharmaceuticals and biotech (18%), labor unions (15%), and lawyers and lobbyists (13%), while individual employed donors similarly reflect work in legal, government, and pharmaceutical sectors. Mullin received $298K in party and leadership funds separate from industry contributions, and has no recorded stock trading disclosures across 147 votes cast.
FOLLOW THE MONEY
Left: who funds Mullin (ribbon width = dollars) · right: their votes on bills classified as favoring vs limiting those sectors
“Favors / limits” is an AI classification of each bill's likely effect on the sector — a factual reading of the bill, not a claim about motive. Correlation, not causation. The named bills are in DOES THE MONEY MATCH THE VOTES? below.
DOES THE MONEY MATCH THE VOTES?
How Mullin voted on bills touching their biggest donor sectors · 6 of 7 shown, ranked by sector money
Each dollar figure is Mullin's total from that donor sector — shown on each related vote, not a per-vote amount. Correlation between funding and votes, not causation; many factors shape any single vote.
TOP SOURCES
UNITED DEMOCRACY PROJECT ('UDP')
PAC
STATE OF CALIFORNIA
employees
GENENTECH
employees
COTCHETT, PITRE & MCCARTHY, LLP
employees
ARTICHOKE JOES
employees
ALIGNMENT SIGNALS
Kevin Mullin (D) sits on the Energy and Commerce committee overseeing Pharmaceuticals & Biotech — their largest tracked donor sector (16%)
Rep. Kevin Mullin (D-CA) serves on the House Committee on Energy and Commerce, which has jurisdiction over the Pharmaceuticals & Biotech sector. Pharmaceuticals & Biotech comprises 15.8% of his identifiable donor base ($0.42M), ranking second among Democratic members of Congress.
Kevin Mullin (D) voted YEA on just 1 of 4 bills classified as favoring their own donor sectors
Kevin Mullin voted in favor of 1 of 4 bills classified by an AI model as favoring Securities & Investment and Technology sectors among his top donors, representing 25% alignment. He voted against HJRES25-119, a congressional disapproval rule classified as favoring Securities & Investment, and opposed the only tracked bill classified as limiting these sectors.
COMMITTEES
SIMILAR DONOR NETWORKS
Members funded by the same industries — overlapping donor networks may reflect shared policy interests.

Bonnie Watson Coleman
D-NJ · House

Nanette Diaz Barragán
D-CA · House

Diana DeGette
D-CO · House

Robin L. Kelly
D-IL · House

Janice D. Schakowsky
D-IL · House

Frederica S. Wilson
D-FL · House